Robotic-assisted laparoscopic nephroureterectomy and bladder cuff excision

Our aim was to show that bladder cuff excision and distal ureterectomy can be safely performed by using the LigaSure device during robotic-assisted laparoscopic nephroureterectomy. A 60-year-old man presented with gross hematuria. He was diagnosed with upper urinary tract transitional cell carcinoma...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Society of Laparoendoscopic Surgeons 2012-04, Vol.16 (2), p.320-324
Main Authors: Ozdemir, A T, Altinova, S, Asil, E, Balbay, M D
Format: Article
Language:English
Subjects:
Carcinoma, Transitional Cell - surgery
Case Reports
Electrocoagulation
Hemostasis, Surgical
Humans
Kidney Neoplasms - surgery
Kidney Pelvis
Laparoscopy - methods
Male
Middle Aged
Robotics
Ureter - surgery
Urinary Bladder - surgery
Urologic Surgical Procedures - methods
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Our aim was to show that bladder cuff excision and distal ureterectomy can be safely performed by using the LigaSure device during robotic-assisted laparoscopic nephroureterectomy. A 60-year-old man presented with gross hematuria. He was diagnosed with upper urinary tract transitional cell carcinoma (TCC) on the left side and was scheduled for robot-assisted laparoscopic surgery. Without changing the patient's position, sealing with the LigaSure atlas for bladder cuff excision and distal ureterectomy was performed. The operating time was 140 minutes from the initial incision to skin closure of all incisions. The estimated blood loss during the surgery was 120 mL. There were no intraoperative or postoperative complications. The Foley drain was removed on day 3 after normal cystographic findings, and the patient was discharged from the hospital on the fourth postoperative day. Robot-assisted nephroureterectomy with distal ureterectomy in the same position using a LigaSure device is a safe alternative for upper tract transitional cell carcinoma.
ISSN:1086-8089
1938-3797
DOI:10.4293/108680812X13427982376662